Bispecific antibodies (VIDEO)

Johns Hopkins Medicine

Caption

The immunotherapy approach is targeted to alterations in the common cancer-related p53 tumor suppressor gene, the RAS tumor-promoting oncogene or T-cell receptor genes. It is in the form of bispecific antibodies, comprising one component that specifically recognizes cancer cells and another component that recognizes immune cells and brings the cancer cells and immune cells together to destroy tumor cells.

Credit

Elizabeth Cook

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.